333 related articles for article (PubMed ID: 28986235)
21. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
Coune PG; Bensadoun JC; Aebischer P; Schneider BL
J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
[TBL] [Abstract][Full Text] [Related]
22. Treadmill exercise alleviates motor deficits and improves mitochondrial import machinery in an MPTP-induced mouse model of Parkinson's disease.
Koo JH; Cho JY; Lee UB
Exp Gerontol; 2017 Mar; 89():20-29. PubMed ID: 28062370
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
[TBL] [Abstract][Full Text] [Related]
24. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Rocha EM; De Miranda B; Sanders LH
Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
[TBL] [Abstract][Full Text] [Related]
25. The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.
Sian-Hulsmann J; Riederer P
Cells; 2021 Mar; 10(3):. PubMed ID: 33803185
[TBL] [Abstract][Full Text] [Related]
26. Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.
Zaitone SA; Abo-Elmatty DM; Shaalan AA
Pharmacol Biochem Behav; 2012 Jan; 100(3):347-60. PubMed ID: 21958946
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
28. The role of alpha-synuclein in the development of the dopaminergic neurons in the substantia nigra and ventral tegmental area.
Tarasova TV; Lytkina OA; Roman AY; Bachurin SO; Ustyugov AA
Dokl Biol Sci; 2016; 466():5-7. PubMed ID: 27021360
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
30. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
[TBL] [Abstract][Full Text] [Related]
31. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
[TBL] [Abstract][Full Text] [Related]
32. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
Chen L; Xie Z; Turkson S; Zhuang X
J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
[TBL] [Abstract][Full Text] [Related]
33. Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization.
Lurette O; Martín-Jiménez R; Khan M; Sheta R; Jean S; Schofield M; Teixeira M; Rodriguez-Aller R; Perron I; Oueslati A; Hebert-Chatelain E
Cell Death Dis; 2023 Nov; 14(11):729. PubMed ID: 37949858
[TBL] [Abstract][Full Text] [Related]
34. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
35. α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca
Paillusson S; Gomez-Suaga P; Stoica R; Little D; Gissen P; Devine MJ; Noble W; Hanger DP; Miller CCJ
Acta Neuropathol; 2017 Jul; 134(1):129-149. PubMed ID: 28337542
[TBL] [Abstract][Full Text] [Related]
36. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
[TBL] [Abstract][Full Text] [Related]
37. Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.
Artyukhova MA; Tyurina YY; Chu CT; Zharikova TM; Bayır H; Kagan VE; Timashev PS
Free Radic Biol Med; 2019 Nov; 144():279-292. PubMed ID: 31201850
[TBL] [Abstract][Full Text] [Related]
38. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
[TBL] [Abstract][Full Text] [Related]
39. Rab7 induces clearance of α-synuclein aggregates.
Dinter E; Saridaki T; Nippold M; Plum S; Diederichs L; Komnig D; Fensky L; May C; Marcus K; Voigt A; Schulz JB; Falkenburger BH
J Neurochem; 2016 Sep; 138(5):758-74. PubMed ID: 27333324
[TBL] [Abstract][Full Text] [Related]
40. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
